KIA
TEVA icon

KCM Investment Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

KCM Investment Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-6,769
Closed -$217K – 545
2017
Q1 		$217K Sell
6,769
-1,780
-21% -$60.7K 0.01% 507
2016
Q4 		$310K Sell
8,549
-363
-4% -$14.5K 0.02% 430
2016
Q3 		$410K Sell
8,912
-415
-4% -$21.7K 0.03% 399
2016
Q2 		$468K Hold
9,327
– – 0.03% 357
2016
Q1 		$499K Buy
9,327
+1,889
+25% +$111K 0.04% 343
2015
Q4 		$488K Hold
7,438
– – 0.04% 345
2015
Q3 		$420K Sell
7,438
-500
-6% -$32.4K 0.03% 366
2015
Q2 		$469K Buy
7,938
+748
+10% +$46.1K 0.04% 361
2015
Q1 		$448K Sell
7,190
-466
-6% -$27.1K 0.04% 363
2014
Q4 		$440K Sell
7,656
-2,381
-24% -$133K 0.04% 355
2014
Q3 		$539K Buy
10,037
+371
+4% +$19.7K 0.05% 307
2014
Q2 		$507K Buy
9,666
+1,940
+25% +$99.2K 0.05% 310
2014
Q1 		$408K Hold
7,726
– – 0.04% 321
2013
Q4 		$310K Sell
7,726
-5,915
-43% -$233K 0.03% 360
2013
Q3 		$515K Sell
13,641
-397
-3% -$15.5K 0.06% 282
2013
Q2 		$550K Buy
+14,038
New +$547K 0.07% 265

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

KCM Investment Advisors's TEVA Position: Q2 2017 in Review

KCM Investment Advisors sold out of Teva Pharmaceuticals (TEVA) in Q2 2017, closing a stake of 6,769 shares — an estimated $217K sold.

KCM Investment Advisors first reported a position in TEVA in Q2 2013 and held it in 16 quarters. The position peaked at $550K in Q2 2013. 648 funds tracked by Wall St. Rank hold TEVA as of Q2 2017.

  • KCM Investment Advisors reported no remaining Teva Pharmaceuticals position as of Q2 2017 after selling out during the quarter.
  • KCM Investment Advisors sold 6,769 Teva Pharmaceuticals shares in Q2 2017, an estimated $217K.
  • KCM Investment Advisors first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 16 quarters.
  • KCM Investment Advisors's Teva Pharmaceuticals position peaked at $550K in Q2 2013.
  • 648 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2017.

Based on KCM Investment Advisors's 13F filing for Q2 2017, filed 10 Aug 2017.